Penicillin Allergy Label Increases Risk of Worse Clinical Outcomes in COVID-19
Lauren W. Kaminsky(Penn State Milton S. Hershey Medical Center), Rana Al–Sadi(Penn State Milton S. Hershey Medical Center)
Cited by 13
Related Papers
Use of omalizumab for management of idiopathic anaphylaxis
|Annals of Allergy Asthma & Immunology|2021|27